l-arginine + placebo

This entry refers to a combination used in clinical trials where one group receives L-arginine and the other receives a placebo, rather than a marketed fixed-dose combination product. L-arginine is an amino acid that serves as a precursor for nitric oxide, which acts as a vasodilator and plays roles in protein synthesis, immune function, hormone secretion (including growth hormone and insulin), wound healing, and cardiovascular health. It is commonly studied for its effects on blood flow disorders (such as angina, peripheral arterial disease), erectile dysfunction, hypertension (including preeclampsia), heart failure, kidney function improvement after transplant, immune modulation, and athletic performance[1][2][4][5][6]. Placebo is an inert substance used as a control in clinical studies to assess the efficacy of active treatments.